These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1763500)

  • 41. Erythrocyte antibodies in liver transplantation: a practical and theoretical problem.
    Blomqvist BI; Eleborg L; Lantz B; Shanwell A; Ericzon BG
    Transplant Proc; 1987 Dec; 19(6):4598-9. PubMed ID: 3321628
    [No Abstract]   [Full Text] [Related]  

  • 42. Genetic abnormalities in the myelodysplastic syndrome.
    Jacobs A
    Acta Haematol Pol; 1991; 22(2):197-202. PubMed ID: 1841492
    [No Abstract]   [Full Text] [Related]  

  • 43. The use of purified lectins in immunhematology.
    Judd WJ
    Transfusion; 1979; 19(6):768-72. PubMed ID: 524434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fever of unknown origin due to preleukemia/myelodysplastic syndrome: the diagnostic importance of monocytosis with elevated serum ferritin levels.
    Cunha BA; Hamid N; Krol V; Eisenstein L
    Heart Lung; 2006; 35(4):277-82. PubMed ID: 16863900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasmodium vivax: merozoite antigens, the Duffy blood group, and erythrocyte invasion.
    Barnwell JW; Wertheimer SP
    Prog Clin Biol Res; 1989; 313():1-11. PubMed ID: 2675110
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical picture and molecular disorders in myelodysplastic (MDP) syndromes].
    Rupniewska ZM
    Pol Arch Med Wewn; 1992 Mar; 87(3):197-208. PubMed ID: 1523148
    [No Abstract]   [Full Text] [Related]  

  • 47. G-CSF improves white blood count in preleukemic patients.
    Oncology (Williston Park); 1989 Oct; 3(10):52. PubMed ID: 2484248
    [No Abstract]   [Full Text] [Related]  

  • 48. Tissue distribution and development of blood group antigens.
    Rouger P; Salmon C
    Rev Fr Transfus Immunohematol; 1982 Dec; 25(6):643-56. PubMed ID: 6763310
    [No Abstract]   [Full Text] [Related]  

  • 49. A new mechanism for immune destruction of red blood cells?
    Garratty G
    Transfusion; 2010 Feb; 50(2):274-7. PubMed ID: 20088838
    [No Abstract]   [Full Text] [Related]  

  • 50. [The Antonio Raichsmemorial lecture. The visible preleukemic phase of the "other acute leukemias." Knowledge, doubts and unknowns].
    Sánchez Fayos J
    Sangre (Barc); 1991 Dec; 36(6):487-95. PubMed ID: 1812582
    [No Abstract]   [Full Text] [Related]  

  • 51. Th polyagglutination with fatal outcome in a patient with massive intravascular hemolysis and perforated tumor of colon.
    Levene NA; Levene C; Gekker K; Sigler E; Merhav H; Berrebi A
    Am J Hematol; 1990 Oct; 35(2):127-8. PubMed ID: 2399903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.
    Karafin MS; Westlake M; Hauser RG; Tormey CA; Norris PJ; Roubinian NH; Wu Y; Triulzi DJ; Kleinman S; Hendrickson JE;
    Br J Haematol; 2018 Jun; 181(5):672-681. PubMed ID: 29675950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spurious automated white cell count with Coulter STKS in the myelodysplastic syndromes suggests the presence of a red cell membrane defect.
    Elghetany MT; Hudnall SD
    Am J Hematol; 1996 May; 52(1):69. PubMed ID: 8638626
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparative studies of the interaction between lectins and Leishmania in agglutination tests and enzyme-linked lectin-biotin assays (ELLBA).
    Kalinin NL; Goncharov DB; Shakhanina KL; Safjanova VM
    Mol Gen Mikrobiol Virusol; 1993; (5):29-31. PubMed ID: 8289844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vicia cretica: a powerful lectin for T- and Th- but not TK- or other polyagglutinable erythrocytes.
    Bird GW; Wingham J
    J Clin Pathol; 1981 Jan; 34(1):69-70. PubMed ID: 7462440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Refractory anemia and preleukemia: an analysis of 92 cases].
    Xu K; Hao Y
    Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):65-8. PubMed ID: 11601200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal IgM cold agglutinins with anti-Pr1d specificity in a patient with peripheral neuropathy.
    Herron B; Willison HJ; Veitch J; Roelcke D; Illis LS; Boulton FE
    Vox Sang; 1994; 67(1):58-63. PubMed ID: 7975454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Biochemistry of Ii blood group system (author's transl)].
    Watanabe K
    Tanpakushitsu Kakusan Koso; 1981 Mar; 26(3):193-207. PubMed ID: 6171016
    [No Abstract]   [Full Text] [Related]  

  • 59. Expression of blood group antigens on red cell microvesicles.
    Oreskovic RT; Dumaswala UJ; Greenwalt TJ
    Transfusion; 1992; 32(9):848-9. PubMed ID: 1281942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pr and Gd antigens.
    Roelcke D
    Rev Fr Transfus Immunohematol; 1981 Feb; 24(1):27-36. PubMed ID: 6261321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.